• IEM 1460: Precision AMPA Blockade for Translation

  2026-09-20

  A translational framework for using IEM 1460 as a selective AMPA receptor blocker in excitotoxicity, synaptic transmission, and neuroprotection research—while distinguishing its evidence base from dual-target IEM-1925 findings.

• Sphingosine-1-phosphate: Assay Workflows

  2026-09-19

  Build receptor-aware S1P experiments that connect rapid GPCR signaling with endothelial behavior and neuronal apoptosis. This practical guide combines fresh-reagent handling, time-resolved assays, controls, and troubleshooting for more reproducible cell-fate and vascular studies.

• Sulfo-Cy5 Carboxylic Acid for Smarter Imaging

  2026-09-19

  Sulfo-Cy5 carboxylic acid supports aqueous, far-red fluorescence workflows with reduced aggregation-related quenching. This article shows how to use it as a measurement tool for nanoparticle biodistribution, immune assays, and protein and peptide labeling without overinterpreting fluorescence.

• Lactylation–KRT19 Axis in NSCLC Senescence

  2026-09-18

  Zhang et al. identify a lactate-responsive H3K18 lactylation–KRT19 pathway that enables non-small cell lung cancer cells to bypass p53–p21-driven senescence. The study connects chromatin regulation, p21 ubiquitination, tumor progression, and CD8+ T-cell function, providing a mechanistic basis for combining KRT19 blockade with anti-PD-1 therapy.

• Firefly Luciferase mRNA as a Translational Probe

  2026-09-17

  A thought-leadership guide to using Firefly Luciferase mRNA as more than a reporter: a mechanistically informed tool for separating RNA chemistry, delivery, translation, and biological response in discovery and translational workflows.

• Liproxstatin-1 HCl: Causal Ferroptosis Assays

  2026-09-17

  Liproxstatin-1 HCl is more than a potent ferroptosis inhibitor: it can serve as a pharmacological rescue tool for separating lipid-peroxidation-driven death from upstream mitochondrial and GPX4 mechanisms. This article presents a causal assay framework for interpreting ferroptosis data across renal, hepatic, and cancer models.

• Tropifexor (LJN452) FXR Research Workflow

  2026-09-17

  Learn how to use Tropifexor (LJN452) in FXR reporter, intestinal barrier, and liver disease model workflows. The guide combines low-nanomolar assay design with practical stock handling, barrier readouts, metabolic context, and troubleshooting.

• ANGPTL4-IQGAP1 Axis Drives Prostate Cancer Chemoresistance

  2026-09-16

  The reference study identifies a paracrine mechanism by which cancer-associated fibroblasts reprogram prostate cancer cell metabolism toward mitochondrial biogenesis and oxidative phosphorylation, reducing chemotherapy responsiveness. Its evidence links CAF-derived ANGPTL4 to membrane IQGAP1 and downstream Raf-MEK-ERK-PGC1α signaling, while also evaluating QGGP as a potential strategy for improving docetaxel response.

• ECL Chemiluminescent Substrate Detection Kit Guide

  2026-09-15

  Use an HRP-based chemiluminescent substrate kit to convert ferroptosis and radiotherapy experiments into measurable protein signals. This workflow connects DHODH, GPX4, and ACSL4 immunoblotting with practical exposure control, assay optimization, and orthogonal validation.

• Acetylcysteine: Redox Design for Complex Assays

  2026-09-15

  Acetylcysteine and N-acetyl-L-cysteine are versatile tools for dissecting glutathione biology, oxidative stress pathway modulation, and mucosal redox chemistry. This article translates lessons from an advanced metastatic TNBC nanoplatform into practical decisions for interpreting redox-sensitive assays without overstating what NAC can prove.

• alpha-ketoglutarate in Reliable Cell Assays

  2026-09-14

  A practical, evidence-based guide to using alpha-ketoglutarate in viability, proliferation, cytotoxicity, and metabolic-reprogramming workflows. It explains how SKU M1277 can support controlled dosing, interpretation of metabolic readouts, and reproducible enzyme-system studies.

• Macrophage TIPE2 Links Mitochondrial Fission to ASC Ferropto

  2026-09-13

  This Nature Communications study identifies a macrophage–adipose stem cell circuit that connects TIPE2 loss, mitochondrial fragmentation, impaired exosomal ferritin delivery, and adipose stem cell ferroptosis in visceral fat. Its findings position macrophage TIPE2 and the IP3R–Ca2+–Drp1 axis as mechanistic targets for understanding obesity-associated adipose dysfunction and metabolic disease.

• Acetylcysteine as a Redox Control in 3D PDAC Models

  2026-09-12

  Acetylcysteine can do more than reduce oxidative stress: in 3D pancreatic cancer models, it can function as a defined redox perturbation for testing tumor–stroma biology. This article translates organoid–fibroblast findings into rigorous assay-design decisions while separating established evidence from hypothesis-driven applications.

• Hepatic sEH, Nrf2, and Osteoporosis

  2026-09-12

  A recent pre-proof study identifies a liver–bone signaling axis in which hepatic soluble epoxide hydrolase (sEH) reduces circulating 14,15-EET, weakens Nrf2-ARE antioxidant signaling, and promotes osteoclastogenesis. By combining clinical samples, an ovariectomy-induced mouse model, liver-specific knockdown, pharmacological inhibition, and transcriptomics, the work links fatty acid epoxide metabolism to redox imbalance and bone loss.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-11

  Wang and colleagues developed a mesoporous organosilica nanoparticle that combines pancreatic acinar-cell targeting with trypsin-triggered release of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the system reduced intracellular calcium overload, inflammatory and necrotic signaling, pancreatic enzyme release, and mortality, although clinical translation remains unestablished.

8590 records 1/573 page Next 12345 下5页 Last page